Proxy firm Glass Lewis backs investor WaterMill's board nominees at Ziopharm Oncology
- ByReuters-
(Reuters) - Proxy adviser Glass Lewis has urged Ziopharm Oncology (NASDAQ:ZIOP) Inc's shareholders to elect all three of investment firm WaterMill Asset Management Corp's proposed...